• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Dr Reddys Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Dr. Reddy's
  • BSE Code : 815.0
  • ISIN : INE089A01031
1,144.20 -18 (-1.55%)
  • As on 31 Mar 2025 (EOD)
  • Today’s Low

    1,140.75
  • Today’s High

    1,159.25
  • Open

    1,159.25
  • Perv Close

    1,162.20
  • 52W Low

    1,092.45
  • 52W High

    1,421.49

Key Indicators

  • P/E(TTM)

    18.42

  • Mar.Cap (₹Cr.)

    95,478.38

  • Div & Yield %

    0.70

  • Book Value(₹)

    322.46

  • Debt-Equity Ratio

    -1.55

  • AGM Date

    28-Mar-2025

  • EPS

    62.12

  • P/E Ratio

    18.42

Financials Ratios

  • Debt-Equity Ratio

    0.06

  • Mar.Cap (₹Cr.)

    95,478.38

  • RONW (%)

    21.64

  • ROCE (%)

    26.59

Score Board

  • Equity (₹ in Cr.)

    83.45

  • BV (₹)

    322.50

  • Sales( ₹ in Cr.)

    19,483.80

  • NP (in Cr.)

    4,284.19

  • NP Var(%)

    63.0

  • Div%

    800.0

  • CPS (₹)

    63.00

  • EPS (₹)

    51.30

  • Traded Value (₹ in Lakhs)

    95,465.87

  • 52 Week High

    1,421.49

  • 52 Week Low

    1,092.45

  • Price BSE

    1144.0

  • Price NSE

    1,144.00

  • Market Capital( in Cr.)

    95,465.87

  • P/C Ratio

    18.10

  • P/E Ratio

    22.30

  • Price Vs.BV

    51.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 19,483.80 16,962.50 14,405.20 13,349.10 11,850.40 10,625.50
Excise Duty 19,325.30 16,338.00 13,921.20 13,236.40 11,023.10 10,502.30
Net Sales 19,483.80 16,962.50 14,405.20 13,349.10 11,850.40 10,625.50
Other Income 862.30 591.30 482.00 801.10 743.20 238.40
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 20,346.10 17,553.80 14,887.20 14,150.20 12,593.60 10,863.90
EXPENDITURE :
Raw Materials 19,325.30 16,338.00 13,921.20 13,236.40 11,023.10 10,502.30
Power & Fuel Cost 19,325.30 16,338.00 13,921.20 13,236.40 11,023.10 10,502.30
Employee Cost 3,085.70 2,832.60 2,434.60 2,270.10 2,030.20 1,931.90
Other Manufacturing Expenses 357.40 406.10 292.00 300.00 245.10 269.80
Selling & Administrative Expenses 3,064.60 2,782.80 2,672.90 2,274.90 2,026.80 2,001.20
Miscellaneous Expenses 357.40 406.10 292.00 300.00 245.10 269.80
Less : Pre-operative Expenses Capitalised :
Total Expenditure 14,554.80 13,687.80 12,663.40 11,094.00 9,817.80 9,163.20
Operating Profit 2,010.40 1,656.00 1,365.70 1,244.30 1,104.90 1,085.10
Interest 21.80 16.90 38.00 46.70 47.80 56.80
Gross Profit 5,791.30 3,866.00 2,223.80 3,056.20 2,775.80 1,700.70
Depreciation 975.60 923.20 814.30 835.00 789.20 780.60
Profit Before Tax 5,791.30 3,866.00 2,223.80 3,056.20 2,775.80 1,700.70
Tax 1,361.80 864.10 392.60 540.10 483.90 281.80
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 87.50 389.10 208.00 329.70 -645.80 141.60
Reported Net Profit 4,342.00 2,612.80 1,623.20 2,186.40 2,937.70 1,277.30
Extraordinary Items 5,791.30 3,866.00 2,223.80 3,056.20 2,775.80 1,700.70
Adjusted Net Profit 4,342.00 2,612.80 1,623.20 2,186.40 2,937.70 1,277.30
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 667.30 666.11 499.28 415.75 415.43 332.13
P & L Balance carried down 4,342.00 2,612.80 1,623.20 2,186.40 2,937.70 1,277.30
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 800.00 800.00 600.00 500.00 500.00 400.00
Dividend Per Share(Rs) 40.00 40.00 30.00 25.00 25.00 20.00
Earnings Per Share-Unit Curr 260.95 157.37 97.85 131.84 177.23 76.98
Book Value 667.30 666.11 499.28 415.75 415.43 332.13
Book Value(Adj)-Unit Curr 667.30 666.11 499.28 415.75 415.43 332.13

Shareholding Pattern

  • Promoter Group

    26.64%

  • Public Share Holding

    73.20%

  • Custodian

    0.16%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 222,305,640 26.64 222,305,640 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 222,305,640 26.64 222,305,640 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1,337,795 0.16 1,337,045 9
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 224,013,586 26.85 224,013,586 828
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 110,414,975 13.23 110,414,975 1
Insurance Companies 74,790,474 8.96 74,790,474 29
Mutual Funds / UTI 92,971,798 11.14 92,971,348 37
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 21,996,482 2.64 21,996,482 23
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 525,525,110 62.98 525,523,910 927
2] Non Institution
Bodies Corporate 3,056,839 0.37 3,046,189 1,574
Clearing Members 2,241,904 0.27 2,241,904 63
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 7,826,385 0.94 7,430,765 12,017
Foreign Non Institution Other 650,622 0.08 650,622 3
Hindu Undivided Families 1,360,652 0.16 1,360,652 3,661
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 659,200 0.08 659,200 2
Individuals holding nominal share capital up to Rs. 1 lakh 66,701,089 7.99 65,477,654 385,385
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 32,450 0.00 32,450 24
Others 2,485,004 0.30 2,485,004 1
Sub Total 85,290,230 10.22 83,660,525 402,731
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 1,302,980 0.16 1,302,980 1
Total Shares held by Custodians and against which Depository Receipts have been issued 1,302,980 0.16 1,302,980 1
Grand Total ( A + B + C ) 834,423,960 100.00 832,793,055 403,669

Company Background

Dr Reddys Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Dr Reddys Laboratories Ltd
  • BSE Code : 815.0
  • ISIN : INE089A01031
  • Incorporation Year

    1984

  • Registered Office

    8-2-337 Road No 3
    Banjara Hills, Hyderabad,
    Telangana-500034

  • Telephone

    91-40-49002900

  • FAX

    91-40-49002999

  • Chairman

    K Satish Reddy

  • Managing Director

  • Company Secretary

    K Randhir Singh

  • Auditor

    S R Batliboi & Associates LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Big Share Services Pvt Ltd
    3rd Flr 306 Rightwin,
    Amrutha Ville,Somajiguda
    Mumbai - Hyderabad-500082

Dr Reddys Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Dr Reddy's Labs 1,144.05 20,346.10 19,483.80 18.42 25.40
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92